UPDATE
: Monday, September 7, 2020
Home
Login
Mobile Version
All
Hospital
Pharma
Bio
Korea‘s Bio Industry
Device/ICT
Policy
People
Life science
Special
Innovation for Survival
Korea’s medical culture series
Korea’s New Candidate Drug Watch List
Special Series in Celebration of KBR's 1st Anniversary
Interview with foreign envoys
Special Series in Celebration of KBR’s 2nd Anniversary
Interview with global pharma
Special Series in Celebration of KBR’s 3rd Anniversary
Special Series in Celebration of KBR’s 4th Anniversary
ASCO 2020 Highlights
Opinion
Reporter’s Notebook
Search
트위터
페이스북
RSS
상단여백
제목보기
제목보기
제목+내용
Drugmakers boost production capacity amid Covid-19
by Kim Chan-hyuk
2020-08-28 14:57
Genexine's cytokine drug effective on severe Covid-19 patients
by Shim Hyun-tai
2020-08-27 18:05
Drugmakers to sue government for limiting choline alfoscerate benefit
by Kim Yun-mi
2020-08-27 14:26
Stocks of 3 Covid-19 vaccine developers spike
by Kim Chan-hyuk
2020-08-27 14:07
Helixmith’s antibody therapy shows efficacy in immunoglobulin kidney disease
by Shim Hyun-tai
2020-08-26 17:47
라인
HK inno.N, T&R Biofab to develop skin therapy using 3D tech
by Shim Hyun-tai
2020-08-26 16:19
Novartis fails trial on skin cancer drug candidate spartalizumab
by Kim Yun-mi
2020-08-26 11:11
CrystalGenomics’ anticancer candidate has FDA’s orphan drug status
by Shim Hyun-tai
2020-08-25 17:07
PharmAbcine, Samsung Biologics sign CDMO deal for antibody candidate
by Shim Hyun-tai
2020-08-25 16:57
Huons' eye drop wins Saudi’s regulatory nod
by Shim Hyun-tai
2020-08-25 14:50
라인
HK inno.N publishes P3 trial results of drug on gastric ulcers
by Shim Hyun-tai
2020-08-24 18:02
Intron Bio secures new drug substance for bacterial pneumonia
by Shim Hyun-tai
2020-08-24 18:01
GC Pharma collects more plasma to speed up work on Covid-19 treatment
by Kim Chan-hyuk
2020-08-24 17:15
Regulator OKs Pfizer’s cardiomyopathy drug Vyndamax
by Shim Hyun-tai
2020-08-24 16:12
Genexine begins global P3 trial of anemia drug
by Shim Hyun-tai
2020-08-24 16:12
라인
Drug sales reps refrain from visiting doctors amid Covid-19 resurge
by Kim Yun-mi
2020-08-21 16:00
Hanmi terminates global P2 trial for poziotinib
by Lee Han-soo
2020-08-21 15:56
Daewoong to co-develop esophagitis drug for treating Covid-19
by Shim Hyun-tai
2020-08-20 18:41
Yuhan licenses out gastrointestinal treatment to US partner
by Lee Han-soo
2020-08-20 16:58
Regulator OKs P2 trial of Covid-19 plasma therapy
by Lee Han-soo
2020-08-20 14:55
-
1
2
3
4
5
6
7
8
9
10
다음
-
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
여백
Most viewed
1
‘Cyramza helped improve gastric cancer treatment in Korea’
2
‘Reduced-dose prasugrel effective for ACS patients undergoing PCI’
3
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
4
SNUBH develops AI model predicting patients at risk of cerebral aneurysm
5
Novavax releases encouraging phase-1 results on Covid-19 vaccine candidate
6
LG Chem, SK Bioscience end sales partnership with Daewoong
7
UBcare wins patent for tech to monitor suspected infectious diseases
8
176 civic groups furious over government-doctors deal
9
Recovered Covid-19 patients suffer from aftereffects – for long
10
Regulator OKs JW Pharma's rheumarthritis drug for treating giant cell arteries
여백
Opinion
[Column] Correct diagnosis leads to proper treatment
[Column] How ongoing doctors’ strike is different from 20 years ago
A Korean-American Doctor asks: Is Korea truly in 2020?
여백
Back to Top